Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...
A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
The first study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia ...